675
Participants
Start Date
October 10, 2018
Primary Completion Date
December 27, 2019
Study Completion Date
December 27, 2019
VaxigripTetra inj.
Suspension for injection in a pre-filled syringe Injection intramuscular
Site 009, Donghae-si
Site 011, Changwon
Site 012, Gwangju
Site 003, Gyeonggi-do
Site 005, Gyeonggi-do
Site 010, Gyeonggi-do
Site 004, Incheon
Site 007, Incheon
Site 008, Incheon
Site 002, Seoul
Lead Sponsor
Sanofi
INDUSTRY